Racial differences in the association of accelerated aging with future cardiovascular events and all-cause mortality: the coronary artery risk development in young adults study, 2007-2018.

Ethnicity & Health
Sarah N ForresterCatarina I Kiefe

Abstract

Variability of Cardiovascular disease (CVD) risk, including racial difference, is not fully accounted for by the variability of traditional CVD risk factors. We used a multiple biomarker model as a framework to explore known racial differences in CVD burden. We measured associations between accelerated aging (AccA) measured by a combination of biomarkers, and cardiovascular morbidity and all-cause mortality using data from the Coronary Artery Risk Development in Young Adults study (CARDIA). AccA was defined as the difference between biological age, calculated using biomarkers with the Klemera and Doubal method, and chronological age. Using logistic regression, we assessed overall and race-specific associations between AccA, CVD, and all-cause mortality. Among our cohort of 2959 Black or White middle-aged adults, after adjustment, a one-year increase in AccA was associated with increased odds of CVD (Odds Ratio (OR) = 1.04; 95% CI: 1.02, 1.06), stroke (OR = 1.12; 95% CI: 1.07, 1.17), and all-cause mortality (OR = 1.05; 95% CI: 1.02, 1.08). We did not find significant overall racial differences, but we did find race by sex differences where Black men differed markedly from White men in the strength of association with CVD (OR = 1...Continue Reading

References

Jan 1, 1988·Journal of Clinical Epidemiology·G D FriedmanP J Savage
Nov 1, 1971·Stroke; a Journal of Cerebral Circulation·A HeymanW Stuart
Aug 21, 2003·JAMA : the Journal of the American Medical Association·Philip GreenlandPeter W Wilson
Aug 21, 2003·JAMA : the Journal of the American Medical Association·Umesh N KhotEric J Topol
Mar 17, 2005·Circulation·George A MensahJanet B Croft
Dec 2, 2005·Mechanisms of Ageing and Development·Petr Klemera, Stanislav Doubal
Dec 29, 2005·American Journal of Public Health·Arline T GeronimusJohn Bound
Feb 16, 2006·Archives of Internal Medicine·Susan G LakoskiStephen B Hulley
Dec 22, 2006·The New England Journal of Medicine·Thomas J WangRamachandran S Vasan
Jan 24, 2007·Hypertension·Thomas J WangRamachandran S Vasan
Mar 20, 2009·The New England Journal of Medicine·Kirsten Bibbins-DomingoStephen B Hulley
Jun 10, 2009·Archives of Internal Medicine·Kristen L KnutsonDiane S Lauderdale
May 28, 2011·Stroke; a Journal of Cerebral Circulation·Salvador Cruz-FloresUNKNOWN Council on Quality of Care and Outcomes Research
Jun 5, 2013·Stroke; a Journal of Cerebral Circulation·Virginia J Howard
Dec 19, 2013·The American Behavioral Scientist·David R Williams, Selina A Mohammed
Jan 23, 2014·Health Psychology : Official Journal of the Division of Health Psychology, American Psychological Association·Kathryn P BrooksTeresa E Seeman
Mar 14, 2014·Journal of Gerontological Social Work·Caroline Rosenthal GelmanAnyelina Peralta
Aug 3, 2014·Social Science & Medicine·M E Levine, E M Crimmins
Aug 13, 2014·Social Science & Medicine·Melvin SeemanTeresa Seeman
Jun 27, 2015·Journal of the American College of Cardiology·Satoru KishiJoão A C Lima
Mar 29, 2016·Health Psychology : Official Journal of the Division of Health Psychology, American Psychological Association·David R WilliamsNorman B Anderson
Jan 27, 2017·Circulation·Emelia J BenjaminUNKNOWN American Heart Association Statistics Committee and Stroke Statistics Subcommittee
Nov 1, 1989·Journal of Cardiopulmonary Rehabilitation·David R JacobsStephen Sidney
Apr 1, 2011·Du Bois Review : Social Science Research on Race·Michelle J SternthalDavid R Williams
Jul 12, 2019·SSM - Population Health·Sarah ForresterCatarina I Kiefe

❮ Previous
Next ❯

Related Concepts

Related Feeds

Biomarkers for Cardiovascular Risk Assessment

Sensitive and accurate biomarkers used in cardiovascular risk prediction can potentially be used to manage the risk of cardiovascular disease. Discover the latest research on Biomarkers for Cardiovascular Risk Assessment here. Discover the latest research on Biomarkers for Cardiovascular Risk Assessment here.

Aging-Associated Metabolic Disorders

Age is associated with many metabolic disorders including cardiovascular diseases, type 2 diabetes, stroke and heart disease. The mediators in aging process have been suggested to play a part in the cellular processes responsible for these metabolic disorders. Here is the latest research on aging-associated metabolic disorders.

Related Papers

Alaska Medicine
B W Mollerstrom
Giornale italiano di cardiologia : organo ufficiale della Federazione italiana di cardiologia : organo ufficiale della Società italiana di chirurgia cardiaca
Gianni Casella, Maddalena Lettino
© 2021 Meta ULC. All rights reserved